These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 5466919)
41. Assay of topical corticosteroids by suppression of experimental inflammation in humans. Kaidbey KH; Kligman AM J Invest Dermatol; 1974 Sep; 63(3):292-7. PubMed ID: 4850664 [No Abstract] [Full Text] [Related]
42. The systemic and local effects of dexamethasone, triamcinolone, 6 alpha-fluorotriamcinolone, and certain of their derivatives, compared by reference to their influence on the foreign-body granuloma, on the weight of the adrenals and thymus, and on the rate of weight gain. Desaulles PA; Samsel J Hormones; 1971; 2(4):204-15. PubMed ID: 5006661 [No Abstract] [Full Text] [Related]
43. Inhibition of prostaglandin biosynthesis by corticosteroids. Greaves MW; McDonald-Gibson W Br Med J; 1972 Apr; 2(5805):83-4. PubMed ID: 5018312 [TBL] [Abstract][Full Text] [Related]
45. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)]. Zaun H; Altmeyer P Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633 [No Abstract] [Full Text] [Related]
46. A comparison of topical corticosteroids: triamcinolone acetonide, prednisolone, fluorometholone, fluorometholone, and hydrocortisone. CAHN MM; LEVY EJ Antibiotic Med Clin Ther (New York); 1959 Dec; 6():734-8. PubMed ID: 13806805 [No Abstract] [Full Text] [Related]
47. The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study. Sarkany I; Hadgraft JW; Caron GA; Barrett CW Br J Dermatol; 1965 Nov; 77(11):569-75. PubMed ID: 5322445 [No Abstract] [Full Text] [Related]
48. Depigmenting action of corticosteroids. Experimental study on guinea pigs. Arnold J; Anthonioz P; Marchand JP Dermatologica; 1975; 151(5):274-80. PubMed ID: 1225665 [TBL] [Abstract][Full Text] [Related]
50. The influence of corticosteroids, griseofulvin and tolnaftate on the in vitro growth of two dermatophytes. Caplan RM; Clabaugh W J Invest Dermatol; 1969 Mar; 52(3):247-54. PubMed ID: 5774352 [No Abstract] [Full Text] [Related]
51. Percutaneous absorption of corticosteroids: systemic effects. Scoggins RB; Kliman B N Engl J Med; 1965 Oct; 273(16):831-40. PubMed ID: 5825903 [No Abstract] [Full Text] [Related]
52. [Vasoconstrictive activity of a new anti-inflammatory agent in man: difluprednate]. Barbier A; Girard J; Lafille C; Hincky M Therapie; 1978; 33(5):607-14. PubMed ID: 741421 [No Abstract] [Full Text] [Related]
53. [Effects and side effects of corticosteroids in allotransplantation]. Klaue P Fortschr Med; 1976 Mar; 94(9):491-500. PubMed ID: 786840 [TBL] [Abstract][Full Text] [Related]
54. Versatile system for partition chromatography of corticosteroids and prediction of their elution curves. Weber DJ; Ennals TR; Mitchner H J Pharm Sci; 1972 May; 61(5):689-94. PubMed ID: 5035775 [No Abstract] [Full Text] [Related]
55. Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro. Zesch A; Schaefer H Acta Derm Venereol; 1974; 54(2):91-7. PubMed ID: 4133027 [No Abstract] [Full Text] [Related]
56. The activity of fluocinonide on diseases and healthy skin in comparison with other topical corticosteroids. Kalkoff KW Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):51-6. PubMed ID: 5291633 [No Abstract] [Full Text] [Related]
57. [Assessment of positive epicutaneous test using a highly-effective corticosteroid ointment]. Swoboda B; Ludvan M Z Hautkr; 1975 May; 50(9):371-7. PubMed ID: 127436 [No Abstract] [Full Text] [Related]